0 1369

Cited 0 times in

O8-4 KEYNOTE-042: 5-year update of first-line pembrolizumab in Asian patients with locally advanced/metastatic PD-L1-positive NSCLC

DC Field Value Language
dc.date.accessioned2023-06-02T01:03:27Z-
dc.date.available2023-06-02T01:03:27Z-
dc.date.issued2022-07-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194619-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleO8-4 KEYNOTE-042: 5-year update of first-line pembrolizumab in Asian patients with locally advanced/metastatic PD-L1-positive NSCLC-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKaoru Kubota-
dc.contributor.googleauthorByoung Chul Cho-
dc.contributor.googleauthorVichien Srimuninnimit-
dc.contributor.googleauthorYu Fan-
dc.contributor.googleauthorJianying Zhou-
dc.contributor.googleauthorLi Zhang-
dc.contributor.googleauthorQing Zhou-
dc.contributor.googleauthorYukio Hosomi-
dc.contributor.googleauthorHiroaki Takeoka-
dc.contributor.googleauthorRinee Mukherjee-
dc.contributor.googleauthorWei Fu-
dc.contributor.googleauthorFabricio Souza-
dc.contributor.googleauthorTony S.K. Mok-
dc.contributor.googleauthorLi Zhang-
dc.identifier.doi10.1016/j.annonc.2022.05.032-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422012303-
dc.citation.volume33-
dc.citation.numbersuppl 6-
dc.citation.startPageS472-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(suppl 6) : S472, 2022-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.